The Recall Desk

State

Nebraska product recalls

73,737 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.

What the numbers show

Total
4,580
Critical
713
Severe
1,345
Most recent
2026-10-28

Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.

These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,737 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

34776–34800 of 78317

  • CriticalFDA (Food)·F-1976-2019·2019-08-14

    Shirakiku Fish Cake Recalled for Undeclared Egg, Milk, and Shellfish

    Wismettac Asian Foods is recalling Shirakiku Fish Cake Gobo Maki due to possible undeclared egg, milk, and shellfish.

    Product
    Shirakiku FISH CAKE GOBO MAKI SK F: 20/ 150G, Net Wt. 5.29 oz. Keep Frozen, 5 pcs. UPC 07441092550 Distributed by Wismettac Asian Foods, Inc. Santa Fe Springs, CA
    Category
    Food
    Distribution
    38 states
  • CriticalFDA (Food)·F-1977-2019·2019-08-14

    Shirakiku Fish Cake Recalled for Undeclared Egg, Milk, and Shellfish

    Wismettac Asian Foods is recalling Shirakiku Fish Cake Ika Maki due to possible undeclared egg, milk, and shellfish.

    Product
    Shirakiku FISH CAKE IKA MAKI SK F; 20/ 150G, Net Wt. 5.29 oz. Keep Frozen, 4 pcs. UPC 074410925567 Distributed by Wismettac Asian Foods, Inc. Santa Fe Springs, CA
    Category
    Food
    Distribution
    38 states
  • SevereFDA (Drugs)·D-1691-2019·2019-08-14

    RXQ Compounding Recalls Ondansetron Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ondansetron 2 mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0158-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1668-2019·2019-08-14

    RXQ Compounding Recalls Inositol/Choline B12:B6 Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Inositol/Choline B12:B6 injection solution because there is a lack of assurance of sterility.

    Product
    Inositol/Choline B12:B6, 50/50/1/0.175 MG/ML INJ SOLN(Sulfa Free Lipostat), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0999-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-2073-2019·2019-08-14

    St Jude Medical Recalls 21 Ellipse DR Implantable Cardioverter Defibrillators

    St Jude Medical is recalling 21 Ellipse DR implantable cardioverter defibrillators due to damaged aluminum wires that may prevent the delivery of high-voltage therapy.

    Product
    ELLIPSE DR, REF: CD2377-36QC Implantable cardioverter defibrillators (ICDs)
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1666-2019·2019-08-14

    RXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydroxocobalamin 1000 mcg/mL injections because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0949-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1704-2019·2019-08-14

    RXQ Compounding Recalls Sodium Bicarbonate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Sodium Bicarbonate 8.4% Injection due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1680-2019·2019-08-14

    RXQ Compounding Recalls MIC Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling MIC (Methionine/Inositol/Choline Chloride) 25/50/50 mg/mL Injection due to a lack of assurance of sterility.

    Product
    MIC (METHIONINE/INOSITOL/CHOLINE CHLORIDE) 25/50/50 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0100-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1638-2019·2019-08-14

    RXQ Compounding Recalls Buffered Lidocaine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Buffered Lidocaine 1%+Epi 1:100,000 Injection Solution because the product lacks assurance of sterility.

    Product
    BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0137-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-2074-2019·2019-08-14

    St Jude Medical Recalls 15 Ellipse DR Cardioverter Defibrillators

    St Jude Medical is recalling 15 Ellipse DR cardioverter defibrillators due to damaged aluminum wires that may prevent high-voltage therapy delivery.

    Product
    ELLIPSE DR, Tiered-therapy cardioverter/defibrillator, REF: CD2411-36C, UDI: 05414734507585
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1673-2019·2019-08-14

    RXQ Compounding Recalls Magnesium, Calcium, and Zinc Vials for Sterility Concerns

    RXQ Compounding LLC is recalling magnesium, calcium, and zinc vials due to a lack of assurance of sterility. The products were distributed nationwide.

    Product
    MAGNESIUM 200 MG/ML/ CALCIUM GLUC 6MG/ML/ ZINC 1MG/ML, 5ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0176-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1649-2019·2019-08-14

    RXQ Compounding Recalls DMPS Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dimercapto-Propanesulfonic 5% (DMPS) injection solution because the product lacks assurance of sterility.

    Product
    DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL, 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0904-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1703-2019·2019-08-14

    RXQ Compounding Recalls Phenylephrine and Lidocaine Ophthalmic Solution

    RXQ Compounding LLC is recalling ophthalmic solution vials due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0918-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1645-2019·2019-08-14

    RXQ Compounding Recalls Dexpantenol Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dexpantenol 250mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    DEXPANTHENOL 250MG/ML (MDV) INJECTION SOLN, 30ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0932-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1675-2019·2019-08-14

    RXQ Compounding Recalls Magnesium Chloride Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Magnesium Chloride Hexahydrate 20% Injection Solution because the product lacks assurance of sterility.

    Product
    MAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0951-50
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1686-2019·2019-08-14

    RXQ Compounding Recalls Morphine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Morphine 1mg/mL in NaCl 0.9% 55mL syringes because the company cannot ensure the product is sterile.

    Product
    MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1660-2019·2019-08-14

    RXQ Compounding Recalls Folic Acid Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Folic Acid 10mg/ml Injection Solution because the product lacks assurance of sterility.

    Product
    FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0921-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1670-2019·2019-08-14

    RXQ Compounding Recalls Ketamine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ketamine 10 mg/mL Injection Solution due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1683-2019·2019-08-14

    RXQ Compounding Recalls Midazolam Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Midazolam 1mg/mL injection syringes because the company cannot assure the product's sterility.

    Product
    MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1661-2019·2019-08-14

    RXQ Compounding Recalls Folic Acid Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Folic Acid 5mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    FOLIC ACID 5MG/ML INJECTION SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0924-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1671-2019·2019-08-14

    RXQ Compounding Recalls Lidocaine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Lidocaine HCL 1% Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    LIDOCAINE HCL 1% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0174-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1708-2019·2019-08-14

    RXQ Compounding Recalls Succinylcholine Chloride Injections Due to Sterility Concerns

    RXQ Compounding LLC is recalling Succinylcholine Chloride 20mg/mL injection vials because the product lacks assurance of sterility.

    Product
    SUCCINYLCHOLINE CHLORIDE 20MG/ML INJ SOL, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0129-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1697-2019·2019-08-14

    RXQ Compounding Recalls Procaine HCL Injectable Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Procaine HCL 20 mg/mL Injectable Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PROCAINE HCL (PFV) 20 MG/ML INJECTABLE SOLUTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0900-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1690-2019·2019-08-14

    RXQ Compounding Recalls Ondansetron Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ondansetron 2 mg/mL Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0157-20
    Category
    Drug
    Distribution
    Distributed nationwide